1. Adams, D. O., Marino, P. A., and Meltzer, M. S., 1981, Characterization of genetic defects in macrophage tumoricidal capacity: Identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets, J. Immunol. 126: 1843–1847.
2. Anderson, S. E., and Remington, J. S., 1974, Effect of normal and activated human macrophages on Toxoplasma gondii, J. Exp. Med. 139: 1154–1174.
3. Boraschi, D., and Meltzer, M. S., 1979a, Macrophage activation for tumor cytotoxicity: Genetic variation in macrophage tumoricidal capacity among mouse strains, Cell. Immunol. 45: 188–194.
4. Boraschi, D., and Meltzer, M. S., 1979b, Defective tumoricidal capacity of mice from A/J 168 Carol A. Nacy et al. mice I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro stimuli, J. Immunol. 122: 1587–1591.
5. Boraschi, D., and Meltzer, M. S., 1979c, Defective tumoricidal capacity of mice from AJJ mice II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice, J. Immunol. 122: 1592–1597.